Form D · Biotechnology

Areteia Therapeutics, Inc.

Chapel Hill, NC · CIK 0001937542

Offering snapshot reported Feb 21, 2025 · SEC filing

Reported sold
$360M
Offering amount: $445M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 15, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$180M$360MJul 14, 2022: $175,000,000.00Jul 14, 2022Feb 22, 2024: $275,000,000.00Feb 22, 2024Feb 21, 2025: $360,000,020.00Feb 21, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$275,000,000 → $360,000,020
  • Reported investors13 → 16

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 21, 2025Amendment$360,000,020$85,000,020vs Feb 22, 202416SEC filing
Feb 22, 2024Amendment$275,000,000$100,000,000vs Jul 14, 202213SEC filing
Jul 14, 2022Initial$175,000,000No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$13M (estimated)
Finders' fees
$0
Form D file number
021-452352

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
COWEN AND COMPANY, LLC7616

Source: Form D, filed Feb 21, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jorge Bartolome Director, Executive
Daniel Becker Director
Whit Bernard Executive
Paul Berns Director
Michael E. Bozik Director
Stephen Butts Director
Christopher Courts Executive
Christopher Todd Cox Executive
Benjamin Gomez Director
Adam Koppel Director
Ian Read Director
Elyse Stock Director
Chris Visioli Executive
Robin Walker Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
101 Glen Lennox Dr. Suite 300
Chapel Hill, NC, 27517